Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ADAP stock have an median target of 1.4, with a low estimate of 0.46 and a high estimate of 1.75. The median target predicts an increase of 400.00% from the current stock price of 0.28.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 0.46 | 1.22 | 1.4 | 1.75 |
| Change | 64.29% | 335.71% | 400.00% | 525.00% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on Adap... Unlock content with Pro Subscription
Updated Apr 01, 2025
| Rating | Jul 24 | Aug 24 | Nov 24 | Mar 25 | Apr 25 | May 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 4 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 4 | 3 | 1 | 2 |
Financial Forecast this Year
Revenue This Year
49.33M
from 178.03M
Increased by -72.3%
Revenue Next Year
70M
from 49.33M
Increased by 41.9%
EPS This Year
-0.09
from -0.28
Increased by 67.9%
EPS Next Year
-0.14
from -0.09
Increased by -55.6%